BioNTech
BioNTech
Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
About
BioNTech SE is a German multinational biotechnology company that develops and commercializes innovative immunotherapies and vaccines, particularly for cancer and infectious diseases. Leveraging its expertise in mRNA technology, immunology, and AI, the company aims to translate scientific discoveries into life-saving treatments and usher in a new era of medicine.
Key facts
At-a-glance profile data
- Website
- biontech.com
- Headquarters
- Mainz, Germany
- Founded
- 2008
- Employees
- 5,128
- Total funding
- $975M (Loan)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Dec 2019 | Loan | $50M | European Investment Bank |
| 10 Oct 2019 | IPO | $150M | - |
| 1 Jul 2019 | Series B | $325M | - |
| 1 Jan 2018 | Series A | $270M | - |
| 1 Jan 2008 | Seed | $180M | MIG Capital |
Tech stack
Detected on biontech.com, last scanned 22 Sept 2026. Run your own scan
- Analytics
- Google Tag Manager
- Hosting
- Azure
- Email provider
- Proofpoint
- Hiring platform
- SAP Jobs2Web
Add first review
Frequently asked
How much funding has BioNTech raised?
BioNTech has raised a total of $975M in funding. The most recent round on record is Loan.
How many employees does BioNTech have?
BioNTech has approximately 5,128 people on record.